D. Karasoy, "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients," Experimental Oncology , vol.38, no.3, pp.187-190, 2016
Karasoy, D. 2016. The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients. Experimental Oncology , vol.38, no.3 , 187-190.
Karasoy, D., (2016). The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients. Experimental Oncology , vol.38, no.3, 187-190.
Karasoy, DURU. "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients," Experimental Oncology , vol.38, no.3, 187-190, 2016
Karasoy, DURU. "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients." Experimental Oncology , vol.38, no.3, pp.187-190, 2016
Karasoy, D. (2016) . "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients." Experimental Oncology , vol.38, no.3, pp.187-190.
@article{article, author={DURU KARASOY}, title={The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients}, journal={Experimental Oncology}, year=2016, pages={187-190} }